As of 2026-03-24, the Relative Valuation of Biodesix, Inc. (BDSX) is (38.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.69 USD, the upside of Biodesix, Inc. based on Relative Valuation is -363.3%.
The range of the Relative Valuation is (36.27) - (48.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 18.1x | 14.6x |
| Forward P/E multiples | 9.9x - 17.0x | 12.6x |
| Fair Price | (36.27) - (48.05) | (38.68) |
| Upside | -346.9% - -427.1% | -363.3% |
| Date | P/E |
| 2026-03-20 | -5.25 |
| 2026-03-19 | -5.75 |
| 2026-03-18 | -5.68 |
| 2026-03-17 | -5.86 |
| 2026-03-16 | -6.10 |
| 2026-03-13 | -6.31 |
| 2026-03-12 | -6.76 |
| 2026-03-11 | -6.73 |
| 2026-03-10 | -6.61 |
| 2026-03-09 | -6.85 |
| 2026-03-06 | -6.63 |
| 2026-03-05 | -5.60 |
| 2026-03-04 | -5.40 |
| 2026-03-03 | -5.47 |
| 2026-03-02 | -5.56 |
| 2026-02-27 | -5.41 |
| 2026-02-26 | -5.02 |
| 2026-02-25 | -4.56 |
| 2026-02-24 | -4.60 |
| 2026-02-23 | -4.51 |
| 2026-02-20 | -4.66 |
| 2026-02-19 | -4.50 |
| 2026-02-18 | -4.44 |
| 2026-02-17 | -4.51 |
| 2026-02-13 | -4.04 |
| 2026-02-12 | -3.82 |
| 2026-02-11 | -3.65 |
| 2026-02-10 | -3.67 |
| 2026-02-09 | -3.50 |
| 2026-02-06 | -3.66 |
| 2026-02-05 | -3.52 |
| 2026-02-04 | -3.64 |
| 2026-02-03 | -3.89 |
| 2026-02-02 | -3.63 |
| 2026-01-30 | -3.59 |
| 2026-01-29 | -3.41 |
| 2026-01-28 | -3.65 |
| 2026-01-27 | -3.91 |
| 2026-01-26 | -3.56 |
| 2026-01-23 | -4.14 |
| 2026-01-22 | -3.92 |
| 2026-01-21 | -3.85 |
| 2026-01-20 | -3.15 |
| 2026-01-16 | -2.78 |
| 2026-01-15 | -2.94 |
| 2026-01-14 | -3.03 |
| 2026-01-13 | -3.49 |
| 2026-01-12 | -2.85 |
| 2026-01-09 | -1.93 |
| 2026-01-08 | -1.97 |